SKP2 and breast cancer: Genistein can induce apoptosis in BRCA wild-type-1 and mutant BRCA cancer cells, induce apoptosis in breast cancer cells by reducing the level of expression of miR-155, micro-RNA, has the potential to inhibit Skp2 expression in breast cancer cells as an anticancer effect [10, 11, 12].